Elekta has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its adaptive Elekta Evo linear accelerator, Elekta Evo CT-Linac.
Also CE-marked in Europe, Elekta Evo is designed with Iris AI-enhanced image reconstruction to improve image-guided radiation therapy (IGRT) treatments. Using Iris high-definition conebeam CT, the system reduces scatter and enhances image reconstruction, according to the firm.
